References
- Lelo A, Miners J O, Robson R A, Birkett D J. Quantitative assessment of caffeine partial clearances in man. Br J Clin Pharmacol 1986; 22: 183–6
- Gu L, Gonzalez F J, Kalow W, Tang B K. Bio-transformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 1992; 2: 73–7
- Tassaneeyakul W, Birkett D J, McManus M E, Tassaneeyakul W, Veronese M E, Andersson T, Tukey R H, Miners J O. Caffeine metabolism by human hepatic cytochromes P450: Contribution of 1A2, 2E1 and 3A isoforms. Biochem Pharmacol 1994; 47: 1767–76
- Hendeles L, Weinberger M, Bighley L. Absolute bioavailability of oral theophylline. Am J Hosp Pharm 1977; 34: 525–7
- Grygiel J J, Wing L MH, Farkas J, Birkett D J. Effects of allopurinol on theophylline metabolism and clearance. Clin Pharmacol Ther 1979; 26: 660–7
- Tang-Liu D-S, Williams R L, Riegelman S. Nonlinear theophylline elimination. Clin Pharmacol Ther 1982; 31: 358–69
- Sato J, Nakata H, Owada E, Kikuta T, Umetsu M, Ito K. Influence of usual intake of dietary caffeine on single-dose kinetics of theophylline in healthy human subjects. Eur J Clin Pharmacol 1993; 44: 295–8
- Sarkar M A, Hunt C, Guzelian P S, Karnes H T. Characterization of human liver cytochromes P-450 involved in theophylline metabolism. Drug Metab Dispos 1992; 20: 31–7
- Sarkar M A, Jackson B J. Theophylline N-demethylations as probes for P4501A1 and P4501A2. Drug Metab Dispos 1994; 22: 827–34
- Wajner M, Harkness R A. Distribution of xanthine dehydrogenase and oxidase activities in human and rabbit tissues. Biochem Biophys Acta 1989; 991: 79–84
- Brazier J L, Ribon B, Desage M. Study of theophylline metabolism in premature human new-borns using stable isotope labelling. Biomed Mass Spectrom 1980; 7: 189–92
- Tang-Liu D-S, Riegelman S. Metabolism of theophylline to caffeine in adults. Res Communic Chem Pathol Pharmacol 1981; 34: 371–80
- Rodopoulos N, Wisén O, Norman A. Caffeine metabolism in patients with chronic liver disease. Scand J Clin Lab Invest 1995; 55: 229–42
- Muir K T, Jonkman J HG, Tang D-S, Kunitani M, Riegelman S. Simultaneous determination of theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography. J Chromatogr 1980; 221: 85–95
- Scott N R, Chakraborty J, Marks V. Determination of the urinary metabolites of caffeine and theophylline by high-performance liquid chromatography. A comparative study of a direct injection and ion-pair extraction procedure. J Chromatogr 1986; 375: 321–9
- Rodopoulos N, Norman A. Determination of caffeine and its metabolites in urine by high-performance liquid chromatography and capillary electrophoresis. Scand J Clin Lab Invest 1994; 54: 305–15
- Thormann W, Minger A, Molteni S, Caslavska J, Gebauer P. Determination of substituted purines in body fluids by micellar electrokinetic capillary chromatography with direct sample injection. J Chromatogr 1992; 593: 275–88
- Lloyd D K, Fried K, Wainer W. Determination of N-acetylator phenotype using caffeine as a probe compound: a comparison of high-performance liquid chromatography and capillary electrophoresis methods. J Chromatogr 1992; 578: 283–91
- Danhof M, Breimer D D. Therapeutic drug monitoring in saliva. Clin Pharmacokinet 1978; 3: 39–57
- Drobitch R K, Svensson C K. Therapeutic drug monitoring in saliva. An update. Clin Pharmacokinet 1992; 23: 365–79
- Rodopoulos N, Höjvall L, Norman A. Elimination of theobromine metabolites in healthy adults. Scand J Clin Lab Invest 1996; 56: 373–83
- Moncrieff J. Determination of theophylline in serum and saliva in the presence of caffeine and its metabolites. J Chromatogr 1991; 568: 177–85
- Krenitsky T A, Spector T, Hall W W. Xanthine oxidase from human liver: purification and characterization. Arch Biochem Biophys 1986; 247: 108–19
- Birkett D J, Miners J O, Attwood J. Secondary metabolism of theophylline biotransformation products in man—route of formation of 1-methyluric acid. Br J Clin Pharmacol 1983; 15: 117–9